Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae after hospital discharge
- PMID: 22998785
- DOI: 10.1016/j.ajic.2012.05.015
Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae after hospital discharge
Abstract
Background: The duration of gastrointestinal colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) may play a major role in the spread of these organisms. We evaluated the time to, and factors associated with, ESBL-E clearance after hospital discharge.
Methods: We retrospectively reviewed prospective surveillance results obtained over 14 years in a 1,000-bed hospital. The surveillance collected demographic, hospital stay, microbiologic, and outcome data. An automatic alert system identified readmitted patients with prior ESBL-E carriage. ESBL-E clearance was defined as a negative rectal screening sample at readmission with no new positive clinical sample during the stay. Variables associated with ESBL-E clearance were identified using a Cox model.
Results: We included 1,884 patients with 2,734 admissions. Four hundred forty-eight patients with readmission screening formed the basis for the study. Of 448 patients with 1 to 16 readmissions, 180 (40%) were persistent carriers. The median time to ESBL-E clearance was 6.6 months. Variables independently associated with clearance was having the first positive culture in a screening sample only (adjusted hazard ratio, 1.31; 95% confidence interval, 1.02-1.69; P = .04) and period 2005-2010 (hazard ratio, 1.88; 95% confidence interval, 1.33-2.67; P < .01).
Conclusion: We found a long duration of ESBL-E carriage after hospital discharge. An automatic alert system was useful for identifying, screening, and isolating previous ESBL-E carriers.
Copyright © 2013 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.
Similar articles
-
Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.Int J Infect Dis. 2012 May;16(5):e371-4. doi: 10.1016/j.ijid.2012.01.008. Epub 2012 Mar 7. Int J Infect Dis. 2012. PMID: 22401750
-
Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia.Clin Infect Dis. 2007 Oct 1;45(7):846-52. doi: 10.1086/521260. Epub 2007 Aug 20. Clin Infect Dis. 2007. PMID: 17806048
-
Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.Int J Med Microbiol. 2015 Jan;305(1):148-56. doi: 10.1016/j.ijmm.2014.12.001. Epub 2014 Dec 9. Int J Med Microbiol. 2015. PMID: 25547265
-
Clinical significance of extended-spectrum beta-lactamases.Expert Rev Anti Infect Ther. 2008 Oct;6(5):671-83. doi: 10.1586/14787210.6.5.671. Expert Rev Anti Infect Ther. 2008. PMID: 18847405 Review.
-
Extended-spectrum β-lactamase-producing Enterobacteriaceae in children: old foe, emerging threat.Clin Infect Dis. 2015 May 1;60(9):1389-97. doi: 10.1093/cid/civ020. Epub 2015 Jan 16. Clin Infect Dis. 2015. PMID: 25595742 Free PMC article. Review.
Cited by
-
Transmission dynamics and control of multidrug-resistant Klebsiella pneumoniae in neonates in a developing country.Elife. 2019 Dec 3;8:e50468. doi: 10.7554/eLife.50468. Elife. 2019. PMID: 31793878 Free PMC article.
-
Molecular Epidemiology, Natural History, and Long-Term Outcomes of Multidrug-Resistant Enterobacterales Colonization and Infections Among Solid Organ Transplant Recipients.Clin Infect Dis. 2022 Feb 11;74(3):395-406. doi: 10.1093/cid/ciab427. Clin Infect Dis. 2022. PMID: 33970222 Free PMC article.
-
Safety and effectiveness of home intravenous antibiotic therapy for multidrug-resistant bacterial infections.Eur J Clin Microbiol Infect Dis. 2015 Jun;34(6):1125-33. doi: 10.1007/s10096-015-2330-0. Epub 2015 Feb 6. Eur J Clin Microbiol Infect Dis. 2015. PMID: 25655757
-
Extended-Spectrum β-Lactamase-Producing Enterobacterales Shedding by Dogs and Cats Hospitalized in an Emergency and Critical Care Department of a Veterinary Teaching Hospital.Antibiotics (Basel). 2020 Aug 27;9(9):545. doi: 10.3390/antibiotics9090545. Antibiotics (Basel). 2020. PMID: 32867088 Free PMC article.
-
Antibiotic Exposure during the Preceding Six Months Is Related to Intestinal ESBL-Producing Enterobacteriaceae Carriage in the Elderly.Antibiotics (Basel). 2022 Jul 15;11(7):953. doi: 10.3390/antibiotics11070953. Antibiotics (Basel). 2022. PMID: 35884207 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources